galactose has been researched along with methotrexate in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (28.57) | 18.7374 |
| 1990's | 4 (19.05) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 7 (33.33) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Bosmann, HB; Kirschbaum, BB | 1 |
| Hirsch, J; Wintersberger, U | 1 |
| Bessell, EM; Courtenay, VD; Foster, AB; Jones, M; Westwood, JH | 1 |
| Lenler-Petersen, P; Søgård, H; Thestrup-Pedersen, K; Zachariae, H | 1 |
| Bacci, G; Fabbri, A; Ferrari, S; Figus, E; Longhi, C; Marchesini, G; Marchi, E; Motta, E | 1 |
| De Bolos, C; Degand, P; Delannoy, P; Emery, N; Huet, G; Kim, I; Verbert, A | 1 |
| Han, JH; Kim, CK; Kim, DS; Oh, YK | 1 |
| Duk, M; Krotkiewski, H; Lisowska, E; Pasek, M; Podbielska, M; Sokolik, R; Szechiński, J | 1 |
| Batliwalla, F; Coblyn, JS; Cui, J; Ercan, A; Gregersen, P; Hazen, MM; Lee, DM; Nigrovic, PA; Royle, L; Rudd, PM; Shadick, N; Weinblatt, ME | 1 |
| Domysławska, I; Gabryel-Porowska, H; Gińdzieńska-Sieśkiewicz, E; Klimiuk, PA; Radziejewska, I; Rojewska, J; Sierakowski, S; Sulik, A | 1 |
| Catrina, AI; Hensvold, AH; Klareskog, L; Lundström, SL; Rutishauser, D; Ytterberg, AJ; Zubarev, RA | 1 |
| Bs, U; K, RP; M Joseph, M; R, S; Sen, A; Tt, S | 1 |
| Ishchenko, AV; Shakhnovich, EI | 1 |
| Kung, HF; Wagner, C | 1 |
| Bishop, CF; Melnykovych, G | 1 |
| Chandraprakash, KS; Pillai, GK; Udupa, N; Umadevi, P | 1 |
| Gabor, F; Göker, E; Güneri, T; Karabulut, B; Karasulu, HY | 1 |
| Goto, M; Kamiya, N; Moniruzzaman, M | 1 |
| Desbrieres, J; Popa, M; Tataru, G | 1 |
| Abdelbary, AA; AbouGhaly, MH | 1 |
| Megrab, NAE; Mokhtar Ibrahim, M; Zidan, AS | 1 |
21 other study(ies) available for galactose and methotrexate
| Article | Year |
|---|---|
Renal glycoprotein: glycosyl transferase activities after administration of folic acid.
Topics: Age Factors; Alpha-Globulins; Animals; Carbon Radioisotopes; Collagen; Cortisone; Fetal Proteins; Folic Acid; Galactose; Glycoproteins; Hexosyltransferases; Injections, Intraperitoneal; Injections, Subcutaneous; Kidney; Male; Methods; Methotrexate; Neuraminic Acids; Transferases | 1974 |
Induction of cytoplasmic respiratory deficient mutants in yeast by the folic acid analogue, methotrexate. I. Studies on the mechanism of petite induction.
Topics: Aerobiosis; Anaerobiosis; Cell Division; Fungal Proteins; Galactose; Glucose; Glycerol; Leucine; Methotrexate; Mitochondria; Mutation; Oxygen Consumption; Saccharomyces; Saccharomyces cerevisiae; Species Specificity; Spectrophotometry; Time Factors; Tritium | 1973 |
Some in vivo and in vitro antitumour effects of the deoxyfluoro-D-glucopyranoses.
Topics: Animals; Antineoplastic Agents; Cell Count; Cells, Cultured; Deoxy Sugars; Fluorine; Galactose; Glucose; Lymphoma; Methotrexate; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Structure-Activity Relationship; Time Factors | 1973 |
Galactose tolerance test and methotrexate-induced liver fibrosis and cirrhosis in patients with psoriasis.
Topics: Administration, Oral; Biopsy; Drug Tolerance; Galactose; Humans; Liver; Liver Cirrhosis; Methotrexate; Psoriasis | 1982 |
High-dose methotrexate treatment and liver function in patients with osteosarcoma.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Antipyrine; Bone Neoplasms; Cisplatin; Doxorubicin; Female; Galactose; Humans; Liver; Liver Function Tests; Male; Methotrexate; Osteosarcoma; Prospective Studies | 1994 |
Benzyl-N-acetyl-alpha-D-galactosaminide inhibits the sialylation and the secretion of mucins by a mucin secreting HT-29 cell subpopulation.
Topics: Acetylgalactosamine; Antigens, Viral, Tumor; Benzyl Compounds; Carbohydrate Sequence; Chromatography, High Pressure Liquid; Colonic Neoplasms; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Galactose; Galactosyltransferases; Glycosylation; HT29 Cells; Humans; Methotrexate; Molecular Sequence Data; Monosaccharides; Mucins; Neuraminidase; Sialic Acids; Sialyltransferases | 1996 |
Enhanced hepatocyte uptake and liver targeting of methotrexate using galactosylated albumin as a carrier.
Topics: Animals; Antimetabolites, Antineoplastic; Cattle; Drug Carriers; Drug Compounding; Drug Delivery Systems; Galactose; Liver; Male; Methotrexate; Rats; Rats, Wistar; Serum Albumin, Bovine; Time Factors; Tissue Distribution | 1999 |
Galactosylation of IgG from rheumatoid arthritis (RA) patients--changes during therapy.
Topics: Adult; Aged; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Enzyme-Linked Immunosorbent Assay; Galactose; Humans; Immunoglobulin G; Infliximab; Lectins; Methotrexate; Middle Aged; Surface Plasmon Resonance | 2006 |
Hypogalactosylation of serum N-glycans fails to predict clinical response to methotrexate and TNF inhibition in rheumatoid arthritis.
Topics: Aged; Arthritis, Rheumatoid; Cohort Studies; Female; Galactose; Humans; Immunoglobulin G; Male; Methotrexate; Middle Aged; Polysaccharides; Predictive Value of Tests; Tumor Necrosis Factor-alpha | 2012 |
Changes of glycosylation of IgG in rheumatoid arthritis patients treated with methotrexate.
Topics: Adult; Arthritis, Rheumatoid; Demography; Female; Fucose; Galactose; Glycosylation; Humans; Immunoglobulin G; Lectins; Male; Methotrexate; Middle Aged; N-Acetylneuraminic Acid | 2016 |
IgG Fc galactosylation predicts response to methotrexate in early rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biomarkers; Female; Galactose; Glycosylation; Humans; Immunoglobulin Fc Fragments; Immunoglobulin G; Male; Methotrexate; Middle Aged; Outcome Assessment, Health Care; Prognosis; Proteomics | 2017 |
Galactomannan armed superparamagnetic iron oxide nanoparticles as a folate receptor targeted multi-functional theranostic agent in the management of cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Folic Acid; Galactose; Humans; Magnetic Iron Oxide Nanoparticles; Magnetic Resonance Imaging; Magnetite Nanoparticles; Mannans; Methotrexate; Mice; Nanoparticles; Neoplasms; Theranostic Nanomedicine | 2022 |
SMall Molecule Growth 2001 (SMoG2001): an improved knowledge-based scoring function for protein-ligand interactions.
Topics: Carbonic Anhydrases; Computing Methodologies; Databases, Factual; Ligands; Metalloendopeptidases; Metals; Molecular Conformation; Protein Binding; Proteins; Quantitative Structure-Activity Relationship; Statistics as Topic; Thermodynamics | 2002 |
Oxidation of C-1 compounds by Pseudomonas sp. MS.
Topics: Amines; Amino Acids; Carbon Dioxide; Carbon Isotopes; Culture Media; Enzyme Induction; Ethanol; Formaldehyde; Formates; Hexoses; Lactates; Methane; Methanol; Methotrexate; Oxidoreductases; Pseudomonas; Pyruvates; Succinates | 1970 |
Specific binding of cortisol in subcellular fractions of HeLa cells: temperature dependence and effects of inhibitors.
Topics: 17-Hydroxycorticosteroids; Arsenicals; Azides; Binding Sites; Cell Nucleus; Chloramphenicol; Cyanides; Cycloheximide; Cytoplasm; Dactinomycin; Depression, Chemical; Dinitrophenols; Female; Fluorouracil; HeLa Cells; Hexoses; Humans; Hydrocortisone; In Vitro Techniques; Iodoacetates; Methotrexate; Microsomes; Mitochondria; Ouabain; Prednisolone; Puromycin; Temperature; Tritium | 1971 |
Effect of macrophage activation on plasma disposition of niosomal 3H-methotrexate in sarcoma-180 bearing mice.
Topics: Animals; Drug Compounding; Hexoses; Macrophage Activation; Methotrexate; Mice; Microspheres; Neoplasm Transplantation; Sarcoma 180; Surface-Active Agents | 1993 |
Controlled release of methotrexate from w/o microemulsion and its in vitro antitumor activity.
Topics: 2-Propanol; Antimetabolites, Antineoplastic; Breast Neoplasms; Caco-2 Cells; Cell Proliferation; Cell Survival; Chemistry, Pharmaceutical; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Drug Stability; Emulsions; Female; Glycerol; Hexoses; Humans; Inhibitory Concentration 50; Methotrexate; Sodium Hydroxide; Solubility; Soybean Oil; Surface-Active Agents | 2007 |
Ionic liquid based microemulsion with pharmaceutically accepted components: Formulation and potential applications.
Topics: Acyclovir; Emulsions; Hexoses; Ionic Liquids; Methotrexate; Myristates; Particle Size; Pharmaceutical Preparations; Polysorbates; Solubility; Surface Properties; Surface-Active Agents | 2010 |
Magnetic microparticles based on natural polymers.
Topics: Aldehydes; Animals; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Carboxymethylcellulose Sodium; Cefotaxime; Cetomacrogol; Chemistry, Pharmaceutical; Cross-Linking Reagents; Delayed-Action Preparations; Diffusion; Drug Carriers; Drug Compounding; Ferric Compounds; Gelatin; Glutarates; Hexoses; Kinetics; Lethal Dose 50; Magnetics; Metal Nanoparticles; Methotrexate; Particle Size; Polysorbates; Pseudomonas aeruginosa; Rats; Solubility; Solvents; Staphylococcus aureus; Surface Properties; Surface-Active Agents; Technology, Pharmaceutical; Toluene | 2011 |
Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study.
Topics: Administration, Cutaneous; Animals; Area Under Curve; Chemistry, Pharmaceutical; Cholesterol; Dermatologic Agents; Drug Carriers; Hexoses; Liposomes; Male; Methotrexate; Microscopy, Electron, Transmission; Models, Statistical; Nanotechnology; Organophosphates; Particle Size; Psoriasis; Rats, Wistar; Skin; Skin Absorption; Solubility; Surface Properties; Surface-Active Agents; Technology, Pharmaceutical | 2015 |
Optimization of methotrexate loaded niosomes by Box-Behnken design: an understanding of solvent effect and formulation variability.
Topics: Administration, Cutaneous; Administration, Topical; Chemistry, Pharmaceutical; Cholesterol; Drug Delivery Systems; Gels; Hexoses; Liposomes; Methotrexate; Skin; Solubility; Solvents; Surface-Active Agents | 2017 |